No | Age | Laterality | Diagnosis | Injection substance | Injection site | Initial duction | Time from onset to surgery (y) | Preoperative duction | Preoperative deviation | Type of surgery† | Follow-up (y) | Final outcome |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 39 | R | OAO | AF | glabella | full | 4.3 | full | XT 35PD | LR Rc 6 mm, MR Rs 4.5 mm | 0.8 | Ø |
2 | 27 | R | OAO | HA | nasal dorsum, glabella | adduction −3, depression − 3 | 0.6 | full | XT 20PD | LR Rc 8 mm, MR Rs 5.5 mm | 0.2 | Ø |
3 | 31 | L | CRAO | HA | nasal dorsum | abduction −3, adduction −1, elevation − 1, depression − 3 | 1.0 | full | XT 40PD, HT 16PD | LR Rc 8 mm, MR Rs 5 mm with infratransposition | 1.6 | Ø |
4 | 19 | L | CRAO | AF | glabella | adduction −1 | 2.9 | full | XT 40PD | 1st: Enophthalmos correction with subperiosteal wedge implant | 3.0 | Ø |
2nd: LR Rc 10 mm, MR Rs 8 mm | ||||||||||||
5 | 24 | R | OAO | HA | nasal dorsum | abduction −3, adduction −3, elevation − 3, depression − 3 | 3.1 | elevation −1 | XT 30PD, HoT 5PD, R DVD | LR Rc 6.5 mm, MR plication 5.5 mm, SR Rc 5 mm | 0.6 | ET 5PD, HoT 16PD |
6* | 30 | R | CRAO | HA | nasal dorsum | abduction −3, adduction −4, elevation − 3, depression − 3 | 0.5 | abduction − 3, depression −1 | ET 18PD, HT 10PD | MR Rc 5 mm, SR Rc 3 mm | 3.7 | ET 6PD, HT 20PD |